Group One Trading
RDY icon

Group One Trading’s Dr. Reddy's Laboratories RDY Stock Holding History

Group One Trading’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,469
Closed -$34.7K – 8550
2025
Q4 		$34.7K Sell
2,469
-831
-25% -$11.7K ﹤0.01% 5895
2025
Q3 		$46.1K Hold
3,300
– – ﹤0.01% 6034
2025
Q2 		$49.6K Buy
+3,300
New +$47.1K ﹤0.01% 5581
2016
Q3 		– Sell
-500
Closed -$5K – 4846
2016
Q2 		$5K Sell
500
-41,500
-99% -$380K ﹤0.01% 4279
2016
Q1 		$380K Buy
42,000
+33,000
+367% +$295K 0.01% 1881
2015
Q4 		$83K Buy
+9,000
New +$98.6K ﹤0.01% 3101
2013
Q3 		– Sell
-11,015
Closed -$80.1K – 5517
2013
Q2 		$83K Buy
+11,015
New +$80.4K ﹤0.01% 2986

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Group One Trading's RDY Position: Q1 2026 in Review

Group One Trading sold out of Dr. Reddy's Laboratories (RDY) in Q1 2026, closing a stake of 2,469 shares — an estimated $34.7K sold.

Group One Trading first reported a position in RDY in Q2 2013 and held it in 7 quarters. The position peaked at $380K in Q1 2016. 249 funds tracked by Wall St. Rank hold RDY as of Q1 2026.

  • Group One Trading reported no remaining Dr. Reddy's Laboratories position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 2,469 Dr. Reddy's Laboratories shares in Q1 2026, an estimated $34.7K.
  • Group One Trading first reported a position in Dr. Reddy's Laboratories in Q2 2013 and held it in 7 quarters.
  • Group One Trading's Dr. Reddy's Laboratories position peaked at $380K in Q1 2016.
  • 249 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.